The leadership team at Gamida Cell has experience in regulatory affairs and global head regulatory affairs from AgenTus Therapeutics, Vice President - Global Regulatory Affairs. Head of Oncology & Rare Disease at IPSEN BIOPHARM LIMITED, and Vice President, Global Regulatory Affairs at Karyopharm Therapeutics Inc. The team also has experience in oncology from Daiichi Sankyo Co., Ltd. as Director Regulatory Affairs. The team is educated from Henley Business School in Foundations of Management and A+.
View all